EDMOND DE ROTHSCHILD HOLDING S.A. - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$11,590
-31.5%
100,0000.0%0.00%
Q4 2022$16,930
-15.4%
100,0000.0%0.00%
-100.0%
Q3 2022$20,000
-60.0%
100,0000.0%0.00%0.0%
Q2 2022$50,000
-12.3%
100,0000.0%0.00%0.0%
Q1 2022$57,000
-6.6%
100,0000.0%0.00%0.0%
Q4 2021$61,000
-37.1%
100,0000.0%0.00%
-50.0%
Q3 2021$97,000
-11.8%
100,0000.0%0.00%
-33.3%
Q2 2021$110,000
+17.0%
100,0000.0%0.00%0.0%
Q1 2021$94,000100,0000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders